(Q48321817)

10 February 2018

title

Comparative aluminum mobilizing actions of deferoxamine and four 3-hydroxypyrid-4-ones in aluminum-loaded rats (English)

1 reference

10 February 2018

0 references

1 reference

1

1 reference

10 February 2018

José L. Domingo

3

1 reference

10 February 2018

author name string

J L Esparza

2

1 reference

10 February 2018

P K Singh

4

1 reference

10 February 2018

M M Jones

5

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

10 February 2018

published in

Toxicology

1 reference

10 February 2018

volume

130

1 reference

10 February 2018

issue

2-3

1 reference

10 February 2018

page(s)

175-181

1 reference

10 February 2018

The use of desferrioximine in dialysis-associated aluminium disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Pharmacokinetics of aluminum 3-hydroxypyridin-4-one complexes: implications for aluminum redistribution subsequent to chelation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Neuropsychological deficit among elderly workers in aluminum production

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Effects of aluminum chloride on normal and uremic adult male rats. Tissue distribution, brain choline acetyltransferase activity, and some biological variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

The use of chelating agents in the treatment of aluminum overload

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Comparative Effects of Several Chelating Agents on the Toxicity, Distribution and Excretion of Aluminium

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Citric, malic and succinic acids as possible alternatives to deferoxamine in aluminum toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Comparative aluminium mobilizing actions of several chelators in aluminium-loaded uraemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

The effect of age on aluminum retention in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Aluminium distribution and excretion: a comparative study of a number of chelating agents in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Aluminium-induced bone disease in uremic rats: effect of deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Future of oral iron chelator deferiprone. (L1) ICOC committee

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Acute Toxicity Studies of Aluminium Compounds: Antidotal Efficacy of Several Chelating Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Structure/activity relationships affecting the ability of monoanionic 3-hydroxyprid-4-ones to mobilize iron

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Bile is an important route of elimination of ingested aluminum by conscious male Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Neurologic Syndrome in 25 Workers From an Aluminum Smelting Plant

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Aluminum chelation by 3-hydroxypyridin-4-ones in the rat demonstrated by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

Aluminum mobilization by desferrioxamine assessed by microdialysis of the blood, liver and brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

PREVENTION AND TREATMENT OF ALUMINUM TOXICITY INCLUDING CHELATION THERAPY: STATUS AND RESEARCH NEEDS

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2898%2900109-7

7 January 2021

10.1016/S0300-483X(98)00109-7

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018